Correction: Infection risk reduction with povidone-iodine rectal disinfection prior to transrectal prostate biopsy: an updated systematic review and meta-analysis
Status PubMed-not-MEDLINE Jazyk angličtina Země Německo Médium electronic
Typ dokumentu tisková chyba
PubMed
39276223
PubMed Central
PMC11401780
DOI
10.1007/s00345-024-05195-8
PII: 10.1007/s00345-024-05195-8
Knihovny.cz E-zdroje
- Publikační typ
- tisková chyba MeSH
Department of Biomedical Sciences Humanitas University Pieve Emanuele Italy
Department of Urology 2nd Faculty of Medicine Charles University Prague Czech Republic
Department of Urology Jikei University School of Medicine Tokyo Japan
Department of Urology Semmelweis University Budapest Hungary
Department of Urology Shariati Hospital Tehran University of Medical Sciences Tehran Iran
Department of Urology Shimane University Faculty of Medicine Shimane Japan
Department of Urology University Medical Center Hamburg Eppendorf Hamburg Germany
Department of Urology University of Texas Southwestern Dallas TX USA
Department of Urology Weill Cornell Medical College New York NY USA
Hourani Center for Applied Scientific Research Al Ahliyya Amman University Amman Jordan
Institute for Urology and Reproductive Health Sechenov University Moscow Russia
Karl Landsteiner Institute of Urology and Andrology Vienna Austria
Zobrazit více v PubMed
Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R et al (2013) Systematic review of complications of prostate biopsy. Eur Urol. 64(6):876–92. 10.1016/j.eururo.2013.05.049 PubMed
Pontes-Junior J, Freire TM, Pugliesi FG, De Moura Costa FM, De Souza VMG, Galucci FP et al (2022) Effectiveness of intrarectal povidone-iodine cleansing plus formalin disinfection of the needle tip in decreasing infectious complications after transrectal prostate biopsy: a randomized controlled trial. J Urol 208(6):1194–1202. 10.1097/JU.0000000000002910 PubMed
Pilatz A, Dimitropoulos K, Veeratterapillay R, Yuan Y, Omar MI, MacLennan S et al (2020) Antibiotic prophylaxis for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis. J Urol. 204(2):224–30. 10.1097/ju.0000000000000814 PubMed
Pu C, Bai Y, Yuan H, Li J, Tang Y, Wang J et al (2014) Reducing the risk of infection for transrectal prostate biopsy with povidone-iodine: a systematic review and meta-analysis. Int Urol Nephrol. 46(9):1691–8. 10.1007/s11255-014-0713-2 PubMed
Ergani B, Çetin T, Yalçın MY, Özbilen MH, Bildirici Ç, Karaca E et al (2020) Effect of rectal mucosa cleansing on acute prostatitis during prostate biopsy: a randomized prospective study. Turk J Urol. 46(2):159–64. 10.5152/tud.2019.19172 PubMed PMC
Ryu H, Song SH, Lee SE, Song KH, Lee S (2019) A prospective randomized trial of povidone-iodine suppository before transrectal ultrasonography-guided prostate biopsy. Medicine 98(12):6. 10.1097/md.0000000000014854 PubMed PMC
Cadilhe JP (2017) Transrectal prostate biopsy after prophylatic preparation of the rectum with povidone-iodine: a prospective randomized trial. J Urol 197:e143
Abughosh Z, Margolick J, Goldenberg SL, Taylor SA, Afshar K, Bell R et al (2013) A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol 189(4):1326–1331. 10.1016/j.juro.2012.09.121 PubMed
Pradere B, Veeratterapillay R, Dimitropoulos K, Yuan Y, Omar MI, MacLennan S et al (2021) Nonantibiotic strategies for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis. J Urol. 205(3):653–63. 10.1097/ju.0000000000001399 PubMed
European Association of Urology:Guideline on Prostate Cancer. Available from: https://uroweb.org/guidelines/prostate-cancer/chapter/diagnostic-evaluation. Accessed on Dec
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD et al (2011) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 343:d5928. 10.1136/bmj.d5928 PubMed PMC
Assel M, Sjoberg D, Elders A, Wang X, Huo D, Botchway A et al (2019) Guidelines for reporting of statistics for clinical research in urology. Eur Urol. 75(3):358–67. 10.1016/j.eururo.2018.12.014 PubMed PMC
Brown RW, Warner JJ, Turner BI, Harris LF, Alford RH (1981) Bacteremia and bacterium after transrectal prostatic biopsy. Urology 18(2):145–148. 10.1016/0090-4295(81)90425-8 PubMed
Sharpe JR, Sadlowski RW, Finney RP, Branch WT, Hanna JE (1982) Urinary tract infection after transrectal needle biopsy of the prostate. J Urol 127(2):255–256. 10.1016/s0022-5347(17)53730-1 PubMed
Melekos MD (1990) Efficacy of prophylactic antimicrobial regimens in preventing infectious complications after transrectal biopsy of the prostate. Int Urol Nephrol 22(3):257–262. 10.1007/bf02550403 PubMed
Ghafoori M, Shakiba M, Seifmanesh H, Hoseini K (2012) Decrease in infection rate following use of povidone-iodine during transrectal ultrasound guided biopsy of the prostate: a double blind randomized clinical trial. Iran J Radiol 9(2):67–70. 10.5812/iranjradiol.7561 PubMed PMC
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801–810. 10.1001/jama.2016.0287 PubMed PMC
American College of Chest Physicians (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 20(6):864–74 PubMed
Valverde A, Msika S, Kianmanesh R, Hay JM, Couchard AC, Flamant Y et al (2006) Povidone-iodine vs sodium hypochlorite enema for mechanical preparation before elective open colonic or rectal resection with primary anastomosis: a multicenter randomized controlled trial. Arch Surg. 141(12):1168–74. 10.1001/archsurg.141.12.1168. (Discussion 75) PubMed
Forsvall A, Fisher J, Cardoso JFP, Wagenius M, Tverring J, Nilson B et al (2021) Evaluation of the Forsvall biopsy needle in an ex vivo model of transrectal prostate biopsy—a novel needle design with the objective to reduce the risk of post-biopsy infection. Scand J Urol. 55(3):227–34. 10.1080/21681805.2021.1921023 PubMed
European Medicine Agency. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics. [December 2022.]. Available from: https://www.ema.europa.eu/en/news/disabling-potentially-permanent-side-effects-lead-suspension-restrictions-quinolone-fluoroquinolone. Accessed on Dec
Hu JC, Assel M, Allaf ME, Ehdaie B, Vickers AJ, Cohen AJ et al (2024) Transperineal versus transrectal magnetic resonance imaging-targeted and systematic prostate biopsy to prevent infectious complications: the PREVENT randomized trial. Eur Urol. 10.1016/j.eururo.2023.12.015 PubMed PMC
Bennett HY, Roberts MJ, Doi SA, Gardiner RA (2016) The global burden of major infectious complications following prostate biopsy. Epidemiol Infect. 144(8):1784–91. 10.1017/s0950268815002885 PubMed PMC